Abstract
The concept of informed consent was one of the most fruitful ideas that deeply changed the relationships between physicians and their patients from paternalism to respect for the personal autonomy of subjects needing professional medical care. The great progress in medicine, also involving the pharmaceutical industry, has created an increasing need to perform different clinical and experimental trials. The evolution of clinical research in the last decades has influenced strongly the design of these studies. One of the most important changes in this field has been the use of placebo groups in double-blind controlled studies. The controversies have involved not only the use of placebo when standard or proven treatment was available, but also some specific problems concerning the procedure of obtaining informed consent in such trials. This paper briefly presents the evolution of informed consent in Poland as well as different ethical and legal problems concerning informed consent and the use of placebo controls in clinical trials.
Similar content being viewed by others
References
Miller F.G., Shorr F. (2002) Ethical Assessment of Industry-Sponsored Clinical Trials: A Case Analysis. Chest 121(4): 1337–1342.
Djulbegovic B., Lacevic M., Cantor A., Fields K.K., Bennett C.L., Adams J.R., Kuderer N.M., Lyman G.H. (2000) The uncertainty principle and industry-sponsored research Lancet 356(9230): 635–638.
Shapiro H.T. & Meslin E.M. (2001) Ethical Issues in the Design And Conduct of Clinical Trials in Developing Countries NEJM 345(2): 139–142.
Nesterowicz M. (1998) Prawo medyczne (Medical Law), Torun, p. 109.
Sosniak M. (1977) Cywilna odpowiedzialnosc lekarza (Civil responsibility of physicians), Warszawa, p. 69.
Critical approach by B. Wertheim: Kilka uwag o odpowiedzialnosci cywilnej lekarzy (Several remarks on civil responsibility of physicians) Palestra 1936, No 4–5.
Dz. U. (Journal of Laws) 1997, no. 28, pos. 28.
Beauchamp R.L. & Childress J.F. (1995) Encyclopedia of Bioethics, pp. 215–20.
Kagarise M.J. & Sheldon G. (2000) Translational Ethics: A Perspective for the New Millennium Arch Surg 135: 39–45.
Miyaji N.T. (1993) The power of compassion: truth-telling among American doctors in the care of dying patients. Social Science & Med. 36(3): 249–64.
Weston B. & Lauria M. (1996) Patient Advocacy in the 1990s NEJM 334(8): 543–544.
Zoll A. (1996) Uswiadomiona zgoda (Informed consent). Zeszyty PAU 5: 9–18.
Syse A. (2000) Norway: valid (as opposed to informed) consent. Lancet 356(9238): 1347–1348.
Mulcahy D., Cunningham K., McCormack D., Cassidy N. & Walsh M. (1997) Informed consent from whom? J.Roy.Coll.Surg.Edinburgh. 42(3): 161–4.
Lembcke B., Specht J., Nippel G. & Caspary W.F. (1998) Structure and quality of German-language gastroscopy information forms from the patients’ viewpoint. Zeitschrift fur Gastroenterologie. 36(9): 829–38.
Kirsch M. (2000) The myth of informed consent. Am. J. Gastroenterol. 95(3): 588–9.
Oxman A., Chalmers I & Sackett DL. (2001) A practical guide to informed consent to treatment. BMJ 323(7327): 1464–1466
Emanuel E.J., Wendler D. & Grady C. (2000) What Makes Clinical Research Ethical? JAMA 283: 2701–2711.
Vanderpool HY. (1996) The Ethics of Research Involving Human Subjects. Frederick, Md: University Publishing Group, pp. 45–58.
Levine R.J. (1988) Ethics and Regulation of Clinical Research. 2nd ed. New Haven, Conn: Yale University Press; 1988
Council for International Organizations of Medical Sciences. International Ethical Guidelines for Biomedical Research Involving Human Subjects. Geneva, Switzerland: CIOMS; 2002.
Partridge A.H., Winer E.P. (2002) Informing Clinical Trial Participants About Study Results. JAMA 288(3): 363–365.
Rothmann K..J & Michels K.B. (1994) The Continuing Unethical Use Of Placebo Controls. NEJM 331(6): 394–398.
Editorial (2002) The better-than-nothing idea: debating the use of placebo controls CMAJ 166(5): 573.
Temple R.J. & Meyer Robert (2003) Continued Need for Placebo in Many Cases: Even When There Is Effective Therapy Arch.Int.Med. 163(3): 371–372.
Temple R. & Ellenberg S.S. (2000) Placebo-Controlled Trials and Active-Control Trials in the Evaluation of New Treatments: Part 1: Ethical and Scientific Issues Ann.Int.Med. 133(6): 455–463.
Ellenberg S.S. & Temple R. (2000) Placebo-Controlled Trials and Active-Control Trials in the Evaluation of New Treatments: Part 2: Practical Issues and Specific Cases Ann.Int.Med. 133(6): 464–470.
Miller FG. & Shorr AF. (2002) Unnecessary Use of Placebo Controls: The Case of Asthma Clinical Trials Arch.Int.Med. 162(15): 1673–1677
World Medical Association. (2002). Revised Declaration of Helsinki: ethical principles for medical research involving human subjects. (with Note of clarification on Paragraph 29 added by the WMA General Assembly, Washington 2002). Available at: http://www.wma.net/policy/b3.htm. Accessed: October 2003
Freedman B., Weijer C. & Glass K.C. (1996) Placebo orthodoxy in clinical research: Empirical and methodological myths. J Law Med Ethics 24(3): 243–51.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zaborowski, P., Górski, A. Informed consent and the use of placebo in poland: Ethical and legal aspects. SCI ENG ETHICS 10, 167–178 (2004). https://doi.org/10.1007/s11948-004-0074-9
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11948-004-0074-9